FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+26.26%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$976M
AUM Growth
+$976M
(+14%)
Cap. Flow
-$7.28M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
57.9%
Holding
70
New
10
Increased
18
Reduced
14
Closed
10
Top Buys
| 1 |
Omnicell
OMCL
|
$31.4M |
| 2 |
CareDx
CDNA
|
$21.1M |
| 3 |
Axogen
AXGN
|
$20.1M |
| 4 |
Arrowhead Research
ARWR
|
$12.5M |
| 5 |
Halozyme
HALO
|
$11.8M |
Top Sells
| 1 |
PFNX
Pfenex Inc.
PFNX
|
$19.6M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$18.6M |
| 3 |
United Therapeutics
UTHR
|
$15.5M |
| 4 |
Zymeworks
ZYME
|
$13.1M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$12.7M |
Sector Composition
| 1 | Healthcare | 72.21% |
| 2 | Communication Services | 3.37% |
| 3 | Energy | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
MEI Pharma
MEIP
$149M
| $11.7M | 1.2% |
+3,763,804
| New | +$11.7M |
|
27
Codexis
CDXS
$218M
| $11.6M | 1.19% |
990,458
-177,564
| -15% | -$2.08M |
|
28
OrthoPediatrics
KIDS
$524M
| $10.3M | 1.05% |
224,042
+103,269
| +86% | +$4.74M |
|
|
KRTX
29
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $9.91M | 1.02% |
+128,200
| New | +$9.91M |
|
|
AMRN
30
Amarin Corp
AMRN
$311M
| $9.41M | 0.96% |
2,236,158
+1,160,700
| +108% | +$4.89M |
|
|
MYOK
31
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $9.22M | 0.95% |
67,662
+9
| +0% | +$1.23K |
|
32
Health Catalyst
HCAT
$228M
| $9.18M | 0.94% |
250,753
+352
| +0.1% | +$12.9K |
|
|
33
Zymeworks
ZYME
$1.07B
| $9.08M | 0.93% |
194,967
-281,723
| -59% | -$13.1M |
|
34
Jazz Pharmaceuticals
JAZZ
$7.99B
| $7.3M | 0.75% |
+51,166
| New | +$7.3M |
|
|
VAPO
35
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $5.47M | 0.56% |
188,541
+192
| +0.1% | +$5.57K |
|
36
Simulations Plus
SLP
$289M
| $5.34M | 0.55% |
70,831
-53,153
| -43% | -$4.01M |
|
|
TPTX
37
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $4.79M | 0.49% |
54,833
-137,996
| -72% | -$12.1M |
|
|
HGEN
38
DELISTED
HUMANIGEN, INC.
HGEN
| $4.26M | 0.44% |
+400,000
| New | +$4.26M |
|
|
LHCG
39
DELISTED
LHC Group LLC
LHCG
| $3.07M | 0.31% |
14,457
-10
| -0.1% | -$2.13K |
|
40
Nano X Imaging
NNOX
$240M
| $2.48M | 0.25% |
+105,500
| New | +$2.48M |
|
41
Invesco S&P SmallCap Health Care ETF
PSCH
$145M
| $2.28M | 0.23% |
17,285
| – | – |
|
42
iShares US Medical Devices ETF
IHI
$4.27B
| $2.27M | 0.23% |
7,580
| – | – |
|
43
iShares Biotechnology ETF
IBB
$5.68B
| $2.26M | 0.23% |
16,713
| – | – |
|
44
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $1.92M | 0.2% |
18,241
| – | – |
|
45
AbbVie
ABBV
$374B
| $524K | 0.05% |
5,981
| – | – |
|
46
Dyne Therapeutics
DYN
$1.92B
| $505K | 0.05% |
+25,000
| New | +$505K |
|
47
Merck
MRK
$210B
| $352K | 0.04% |
4,247
| – | – |
|
48
Sanofi
SNY
$122B
| $334K | 0.03% |
6,650
| – | – |
|
|
DYNT
49
DELISTED
Dynatronics Corp
DYNT
| $324K | 0.03% |
461,675
+6,020
| +1% | +$4.23K |
|
50
Johnson & Johnson
JNJ
$429B
| $322K | 0.03% |
2,161
| – | – |
|